Australian medtech company Oventus (ASX: OVN) is surging ahead with its plans to expand into the United States, having reached an agreement with healthcare provider Aeroflow Healthcare for Oventus’ Sleep Treatment Platform and consumables. The partnership will see Aeroflow offer Oventus products under subcontracts which will initially be introduced in the Southeastern States before being
Read More
With mental health issues continuing to make headlines as greater importance is placed on its value towards wellbeing, medtech company Medibio (ASX: MEB) is developing a Software Medical Device for early detection of depressive symptoms. Sleep disorders, their onset, and progression, will be the key depressive symptom being targeted by Medibio’s technology which will be
Read More
Australian healthtech company Azure Healthcare (ASX: AZV) is set to further stamp their footprint on the United States healthcare system with a 3-year extension of their supply agreement for the Company’s nurse call systems which service more than 30 states. The Tacera Pulse system is used to monitor nurse call alarms, collect alarm and response
Read More
Medtech company G Medical Innovations (ASX: GMV) is preparing to launch Prizma – a smartphone case that can monitor vital signs – in Taiwan, having secured Taiwan Food and Drug Administration approval for their flagship device. The approval comes via G Medical’s partner in Taiwan, First Channel Ltd (FCL) which will immediately commence discussions with
Read More
Medtech innovator, G Medical Innovations (ASX: GMV), have experienced a significant boost in market confidence, following the news that the company has experienced 105% growth in their remote patient monitoring service in the US since January this year. The news saw GMV shares close at a striking 33.3% higher yesterday. The impressive year-on-year growth (CY2018-19)
Read More
Confirming their commitment announced in April 2019, the Morrison Government has signed a $5 million grant to Australian medtech company PainChek (ASX: PCK) which will provide dementia patients with licences to utilise the facial recognition software for the purpose of assessing pain. Key to the software which has been clinically tested is its ability to
Read More